|
|
- 2018
卵巢癌分子分型及其临床应用的研究进展DOI: 10.3971/j.issn.1000-8578.2018.17.0771 Keywords: Two Cases Report,卵巢癌血清新型肿瘤标志物研究与应用现况,Expression and Clinical Significance of LncRNA KCNQ1OT1 in Ovarian Cancer Tissues,Clinical Value of Pharmacokinetic Monitoring of Serum Paclitaxel Concentration in Paclitaxel-based Chemotherapy on Patients with Ovarian Cancer,Expression of IRSp53 in Epithelial Ovarian Carcinoma and Its Prognostic Significance,Molecular Classification of Common Solid Cancers Abstract: 摘要 卵巢癌是女性生殖系统第二常见的恶性肿瘤，存在高度异质性。卵巢癌分子分型概念的提出，为探索其异质性、预后评估及个体化治疗方案等方面提供了新依据。本文就卵巢癌的分子分型及临床应用的研究进展作一综述
|
